focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Follower of what exactly
Hi there Moniman. Good advice !!
Hallsworthy also added to the Green bin yet another Totally Deluded follower.
Why does it smell like a placing exactly? Or was that a lazy throwaway remark. It's down because it went up too fast, simple as that. rsi too high, macd just crossed negative, stoch on a sharp decline. 11.75 is pretty much a certainty, with 10 the next obvious level of support then 8 after that. I don't expect it to hit that low, but if news doesn't come before year end, that could easily happy. You pays your money, you takes your chance
@Spuddy just filter them, I saw 3 green boxes in quick succession, they're annoyed cause they've been given a taste of their own trolling medicine on their favourite spamming boards.
Of course there will be no fund raise before share price rises 200/300 % and perhaps prior to Nasdaq listing. 12m sterling is in the bank and prudently managed. Polb-001 is becoming more valuable every day. I get the sneaky suspicion that Polbeg are looking for orphan status for Polb-001. If granted it would make it even more valuable. Obviously before concluding a deal you want all details relating to Polb-001 denomination resolved plus extensive IP patenting in place. So whilst the shorters play their games the wise investor should hold and be patient. We will be rewarded very nicely !!!
Have they spent the £12m?
@ 10p
Smells a like a placing enroute.
Ah ha - Looks like a worked sell of 600k+. Hopefully now they are out, we can continue upward!?
Your 13p has been blown away. Not even much buying in the 12s. It's all one way down.
Strange the 30% movement last week (I'm not complaining btw!) but for then nothing of note to be announced, seems a bit strange. Hope we at least stay around the 13p - 13.5p mark.
Sorry I thought something new. This was rolled out at the Web event and the behcets is a cut and paste from his last venture partner.
Scroll down to company presentations just click on it it’s all there Peter.
Where is this presentation please tiger, normally I can find stuff, this I can't.
New presentation out featuring Behcets disease.
Good luck to all here to and have a good weekend to :)
@Peterrr, yes, agreed, good to see.
Ultimately, POLB is up approximately 25% since IPO, and although patience is required, I am very pleased with the quality and quantity of the development pipeline — plus a team with a good track record and the right expertise.
I am particularly enthused by POLB-001 and its application in therapy-induced CRS.
I do believe that POLB-001 could potentially be valuable in relapse/remitting autoimmune diseases where it could be used in short-term bursts to tamp down 'flares'.
In those cases, the issues around non-stop long-term use are greatly ameliorated, especially given it may avoid patients having to progress onto systemic steroid treatment.
Very interested to see where that goes in future.
Impressive TLY - only down a mere 68% from this time last year ! & 46p to 7p in under 2 years ! You really do have Warren Buffet shaking in his boots with your impressive tipping skills :-)
You must be over the moon with that one.
There you go, as expected, lots of churning over the past few days.
Who was gullible enough to be buying at 15-16p?
I see TLY is up another 8% - I see the Polb/HVO boys are quiet on that one.
Broker Rating 38p. Year high also broken during the week. Buy and hold. Peeps will get well rewarded. News to flow as well. Dyor
Mms filling orders again. Watch the but after hours or later on in the morning
All good, management remuneration still heavily weighted to performance based equity, so not so much cash burn. Nothing unexpected in the accounts.
RNs out. Annual report out
Massive buy printed. Mms filling orders.
Mms hoovering as many shares as they can.